ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Q2 revenue rose 14.1% to ₹135.6 Cr and EBITDA 23.9%, driven by occupancy and volume. Raipur break-even slipped from Q3 FY27 to Q1 FY28 amid ~₹9 Cr Q2 losses. Management gave no new quantified targets beyond FY27 growth.
Q2 FY27 revenue ₹135.6 Cr (+14.0%), EBITDA ₹29.8 Cr (21.5% margin), PAT ₹15.4 Cr (+45.2%). H1 PAT ₹28.1 Cr (+53.9%). Eastern India expansion; 1,000-bed target.
GPT Healthcare shows strong 18.2% revenue growth and 66% PAT growth, but struggles with utilization outside its core Kolkata market.
GPT Healthcare reported Q1FY27 revenue of ₹126.2 Cr, up 17.8% YoY, with EBITDA margins improving to 20.4%. The company is executing a proximity-based model in Eastern India.
GPT Healthcare reported Q4 FY26 revenue of ₹128cr (+24% YoY) and EBITDA margin of 19.5%. FY26 revenue stood at ₹478.5cr with an 18.8% margin.
GPT Healthcare delivered strong FY26 results with 24% YoY revenue growth in Q4, driven by the Raipur hospital scale-up and improved utilization in mature facilities like Salt Lake.
GPT Healthcare reported FY26 revenue of ₹478.5 Cr (up 15.1% YoY) and PAT of ₹42.2 Cr. Growth is driven by stronger clinical mix and the new Raipur hospital.